Efficacy 0f fasd venesection and tila in dawali primary varicose vein a randomised controlled clinical trail

Diagnosed cases of primary varicose vein fulfilling the inclusion criteria will be randomly selected after obtaining written informed consent. Participants will be randomly allocated into two groups, with 24 patients in each group. The test group will be treated with fasd and local application of tila daily for 14 days, while the control group will be treated with compression stockings for 14 days. Patients will be assessed for primary and secondary outcome measures at baseline and after completion of the treatment period. The significance of differences between the two groups will be analyzed using appropriate statistical tests.